Estrogen was also shown to alter inflammatory cytokine and chemokine expression in mast cells in opposite directions depending on the epigenetic status and transcriptional activity of estrogen receptors, which in turn are implicated in CP/CPPS and prostate cancer development. This evidence concerns the gene ESR1 and prostate cancer.